1. A method of reducing neurodegeneration in animals, comprising administering to animals an amount of melatonin that reduces neurodegeneration. 2. The method according to claim 1, wherein melatonin is administered in amounts of from about 0.2 ng / kg / day to about 10 ng / kg / day. The method of claim 1, wherein melatonin is administered in an edible mixture. The method of claim 3, wherein melatonin is administered as a dietary supplement. The method of claim 3, wherein the edible mixture is a food composition. The method of claim 1, wherein the animal is a human or companion animal. The method according to claim 6, in which the companion animal is an animal from the canine or cat family. A method of inhibiting mTOR expression in animals, comprising administering mTOR expression inhibitory amounts of melatonin to animals. The method of claim 8, wherein melatonin is administered in amounts of from about 0.1 ng / kg / day to about 10 ng / kg / day. The method of claim 8, wherein melatonin is administered in an edible mixture. The method of claim 10, wherein melatonin is administered as a dietary supplement. The method of claim 8, wherein the animals are a human or companion animal. The method of claim 12, wherein the companion animal is an animal from a canine or feline family. A method for inhibiting the expression of S6 kinase in animals, comprising administering amounts of melatonin inhibition of S6 kinase expression to animals. The method of claim 14, wherein the melatonin is administered in amounts of from about 0.1 ng / kg / day to about 10 ng / kg / day. The method of claim 14, wherein the melatonin is administered in an edible mixture. The method of claim 16, wherein melatonin is administered as a dietary supplement. The method of claim 16, wherein the edible mixture is a food composition. The method of claim 18, wherein the food composition is1. Способ снижения нейродегенерации у животных, включающий введение животным снижающих нейродегенерацию количеств ме
